We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Doctor's Choices Influenced by Lab Test Cost

By LabMedica International staff writers
Posted on 23 Apr 2013
When doctors know what hospitals charge for certain lab tests, they order far fewer of them or look for cheaper alternatives. More...


Investigators discovered that currently hospitals generally do not disclose the price of lab tests to doctors and this contributes to the high cost of health care in the US.

A six-month study looked at the use of 62 diagnostic blood tests frequently ordered for patients at the Johns Hopkins Hospital (Baltimore, MD, USA) Doctors in one group were given the cost of each of the tests while doctors in another group were not provided with that information.

The group of doctors who knew the prices ordered nearly 9% fewer lab tests, which saved more than USD 400,000 over the study period, according to the study appearing April 15, 2013, in the journal JAMA Internal Medicine. There was a 6% increase in the number of tests ordered by the group of doctors who did not know the prices.

"We generally don't make decisions based on what is cost-effective or what is known to be absolutely necessary for our patients, but knowing the cost of things appears to make us more thoughtful about what we think might be best for their health," study leader Dr. Leonard Feldman, an assistant professor of medicine at Johns Hopkins, said in a hospital news release. He added, "There's a lot of waste in medicine because we don't have a sense of the costs of much of what we do."

Feldman said the findings offer "evidence that presenting providers with associated test fees as they order is a simple and unobtrusive way to alter behavior. In the end, we ordered fewer tests, saved money, and saved patients from extra needle sticks without any negative outcomes."

Many of the savings seen in the study were the result of comparison-shopping. For example, it cost USD 15.44 for a comprehensive metabolic panel, a blood test that checks fluid and electrolyte status, kidney and liver function, blood sugar levels, and response to various medications. A basic metabolic panel checks many of the same things but costs USD 3.08.

During the six-month study, the number of comprehensive metabolic panel tests ordered by doctors who knew the price fell by about 8,900, while the number of basic metabolic panels grew by about the same number. That shift alone saved more than USD 27,000 over the study period, the scientists said.

Related Links:

Johns Hopkins Hospital



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.